Evidence for myocardial salvage in human clinical ischaemia

  • P. G. Hugenholtz
  • J. W. Deckers
  • W. J. van der Giessen
  • P. S. Serruys
  • J. Lubsen

Abstract

It is generally accepted that ischaemic injury to the myocardium arises from an imbalance between myocardial oxygen supply and demand. When ischaemia is brief, as is usually the case with stable angina, and there is already considerable narrowing in one or more of the coronary arteries, a relative decrease in reserve will manifest itself when demand is suddenly increased as a result of augmented work of the heart. When the decrease in oxygen supply is primary, when coronary flow decreases as a function of increased resistance in the coronary arterial and capillary system, the degree of ischaemia is often more severe. At other times this condition may be brief and transitory, with no residual damage.

Keywords

Placebo Lactate Aspirin Radionuclide Diazepam 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Additional References

  1. ANDERSON, J.L., MARSHALL, H.W., BRAY, B.E., LUTZ, J.R., FREDERICK, P.R., YANOWITZ, F.G., DATZ, F.L., KLAUSNER, S.C. and HAGAN, A.D. (1983). A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N. Engl J. Med., 308, 1312–1318.PubMedCrossRefGoogle Scholar
  2. BOUCEK, R.J. and MURPHY, W.P., Jr (1960). Segmental perfusion of the coronary arteries with fibrinolysis in man following acute myocardial infarction. Am. J. Cardiol., 6, 525–533 Eur Heart J., 4, Suppl. D, 73–78.Google Scholar
  3. BRAUNWALD, E. and KLONER, R.A. (1982). The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation, 66, 1146–1149.PubMedCrossRefGoogle Scholar
  4. BUSSMANN, W.D., PASSEK, D., SEIDEL, W. and KALTENBACH, M. (1981). Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerine. Circulation, 63, (3) 615;622.Google Scholar
  5. CHATTERJEE, K. and PARMLEY, W.W. (1983). Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure. J. Am. Coll. Cardiol., 1, 133–153.PubMedCrossRefGoogle Scholar
  6. COHN, J.N., FRANCIOSA, J.A., FRANCIS, G.S., ARCHIBALD, D., et al. (1981). Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure. Results of a Veterans Administration Cooperative Study. N. Eng. J. Med., 19, 1129–1135.Google Scholar
  7. DE JONG, J.W., HARMSEN, E., DE TOMBE, P.P. and KEYZER, E. (1982). Nifedipine reduces adenine nucleotide breakdown in ischemic rat heart. Eur. J. Pharmacol., 81, 89–96.PubMedCrossRefGoogle Scholar
  8. DE JONG, J.W., HARMSEN, E., DE TOMBE, P.P. and KEYZER, E. (1983). Energy conservation in ischemic rat heart by nifedipine plus propranolol. Eur. Heart J., 4, Suppl C. 25–31.Google Scholar
  9. DE WOOD, M.A., SPORES, J., NOTSKE, R., MOUSER, L.T., BURROUGHS, R., GOLDEN, M.S. and LANG, H.T. (1980). Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N. Eng. J. Med., 303, 897–902.CrossRefGoogle Scholar
  10. DURRER, J.D., LIE, K.I., VAN CAPELLE, J.L. and DURRER, D. (1981). Effect of sodium nitroprusside on mortality in acute myocardial infarction. N. Eng. J. Med., 304, 1121–1128.CrossRefGoogle Scholar
  11. FROHNER, K., KOHN, H., BIALONCYK, CH., UNGER, G., MEISL, F., PODCZECK, A., MOSTBECK, A. and STEINBACH, K. (1984). Beurteilung der System-Google Scholar
  12. ischen Fibrinolysen Beim Acuten Myokardinfarkt mit Radionukleid Ventrikulographie und 201 Thallium Szintigraphie. Zeitschr. für Kardiol., 73, Suppl 1, 74.Google Scholar
  13. GERSTENBLITH, G., OUYANG, P., ACHUFF, S.C., BULKLEY, B.H., BECKER, L.C., MELLITS, E.D. (and 6 OTHERS). (1982). Nifedipine in unstable angina: a double blind randomized trial. N. Eng. J. Med., 306, 885–894.CrossRefGoogle Scholar
  14. HARMSEN, E. (1984). Myocardial Purine Metabolism. Thesis. (Editors Note: No further details given).Google Scholar
  15. HENNING, R.J., BECKER, H., VINCENT, J.L., THIJS, L., KALTER, E. and WEIL, M.H. (1981). Use of methylprenisolone in patients following acute myocardial infarction, hemodynamic and metabolic effects. Chest, 79, 186–194.PubMedCrossRefGoogle Scholar
  16. HJALMARSON, A., HERLITZ, J., HOLMBERG, S., RIJ’DEN, L., SWEDBERG, K., VEDIN, A. (and 6 OTHERS). (1983). The Goteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction. Circulation, 67 (6,2), 126–132.Google Scholar
  17. HOOGHOUDT, T.E.H., SERRUYS, P.W., REIBER, J.H.C., SLAGER, C.J., VAN DEN BRAND, M. and HUGENHOLTZ, P.G. (1982). The effect of recanalization of the occluded coronary artery in acute myocardial infarction on left ventricular function. Eur. Heart J., 3, 416–421.PubMedGoogle Scholar
  18. HUGENHOLTZ, P.G., MICHELS, H.R., SERRUYS, P.W. and BROWER, R.W. (1981). Nifedipine in the treatment of unstable angina, coronary spasm and myocardial ischemia. Am. J. Cardiol., 47, 163–175.PubMedCrossRefGoogle Scholar
  19. HUGENHOLTZ, P.G. and SIMOONS, M.L. (1984). Thombolytic therapy for acute myocardial infarction, Hammersmith Cardiology Workshop Series, Raven Press 1, 175–184.Google Scholar
  20. THE INTERNATIONAL COLLABORATIVE STUDY GROUP (1984). Reduction of infarct size with the early use of timolol in acute myocardial infarction, N. Eng. J. Med., 310, 9–15.CrossRefGoogle Scholar
  21. JAFFE, A.S., GELTMAN, E.M., TIEFENBRUNN, SA.J., AMBOS, H.D., STRAUSS, H.D., SOBEL, B.E. and ROBERTS, R. (1983). Reduction of infarct size in patients with inferior infarction with intravenous glyceryl trinitrate. A randomized study. Br. Heart J., 49, 452–460.PubMedPubMedCentralCrossRefGoogle Scholar
  22. JENNINGS, R.B., GANTE, C.E. and REIMER, K.A. (1975). Ischemic Tissue Injury, Am. J. Pathol., 81, 179–198.PubMedPubMedCentralGoogle Scholar
  23. KENNEDY, J. W., RITCHIE, J.L., DAVIS, K.B. and FRITZ, J.K. (1983). Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction. N. Eng. J. Med., 309, 1477–1482.CrossRefGoogle Scholar
  24. LANGE, L.G. and SOBEL, B.E. (1982). Pharmacological salvage of myocardium A. Rev. Pharmac. Toxicol., 22, 115–143.CrossRefGoogle Scholar
  25. LEWIS, H.J.Jr, DAVIS, J.W., ARCHIBALD, D.G., STEINKE, W.E., SMITHERMAN, T.C., DOHERTY, J.E. (and 7 OTHERS). (1983). Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N. Eng. J. Med., 309, (7) 396–403.Google Scholar
  26. MADIAS, J.E. and HOOD, W.B.Jr (1982). Effects of methyl-prenisolone on the ischemic damage in patients with acute myocardial infarction. Circulation, 65, 1106–1113.PubMedCrossRefGoogle Scholar
  27. MATHEY, D.G., RODEWALD, G., RENTROP, P. et al. (1981). Intracoronary streptokinase thrombolytic recanalization and subsequent surgical bypass of remaining atherosclerotic stenosis in acute myocardial infarction: Complementary combined approach effecting reduced infarct size, preventing infarction, and improving left ventricular function. Am. Heart J., 102, 1194–1201.PubMedCrossRefGoogle Scholar
  28. MERX, W., DORR, R., RENTROP, P., BLANKE, H., KARSCH, K.R., MATHEY, D.G., KREMER, P., RUTSCH, W. and SCHMUTZLER, H. (1981). Evaluation of the effectiveness of intracoronary streptokinase infusion in acute myocardial infarction: Postprocedure management and hospital course in 204 patients. Am. Heart J., 102, 1181–1187.PubMedCrossRefGoogle Scholar
  29. MEYER, J., ERBEL, R. and SCHMITZ, H-J. (1984). Transluminale Angioplastik. Zeitschr. für Kardiol., 73, 73.Google Scholar
  30. MULLER, J.E., MORRISON, J., STONE, P.H., RUDE, R.E., ROSNER, B., ROBERTS. R. (and 9 OTHERS). (1984a). Nifedipine therapy for patients with threatened and acute myocardial infarction a randomized double blind, placebo-controlled comparison. Circulation, 69,4, 740–747.PubMedCrossRefGoogle Scholar
  31. MULLER, J.E., TURI, G.T., PEARLE, D.L., SCHNEIDER, J.F., SERFAS, D.H., MORRISON, J. (and 9 OTHERS). (1984b). Nifedipine and conventional therapy for unstable angina pectoris: a randomized double blind comparison. Circulation, 69,4, 728–739.Google Scholar
  32. NAYLER, W.G., FERRARI, R. and WILLIAMS, A. (1980). Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischernic and reperfused myocardium Am. J. Cardiol., 46, 242–248.PubMedCrossRefGoogle Scholar
  33. PARRATT, J.R. (1983). Pharmacological agents to aid the clinician in combatting myocardial ischemia. Eur. Heart J., 4, Suppl.D. 91–99.Google Scholar
  34. RENTROP, P., BLANKE, H., KARSCH, K.R., RUTSCH, W., SCHARTL, M., MERX, W., DÖRR, R., MATHEY, D. and KUCK, K. (1981). Changes in left ventricular function after intracoronary streptokinase infusion in clinical evolving myocardial infarction. Am. Heart J., 102, 1188–1193.PubMedCrossRefGoogle Scholar
  35. RENTROP, P., BLANKE, H., KOSTERING, K. and KARSCH, K.R. (1979). Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase in combination with transluminal recanalization. Clin. Cardiol., 5, 354.CrossRefGoogle Scholar
  36. ROBERTS, R. (1983). Intravenous nitroglycerin in acute myocardial infarction. Am. J. Med., 74, (6b) 45–52. ROBERTS, R. and ISHIKAWA, Y. (1983). Enzymatic estimation of infarct size during reperfusion. Circulation, 68, (2,2) 183–189.Google Scholar
  37. ROSS, J., THEROUX, P., SASAYMA, S., McKOWN, C. and FRANKLIN, D. (1975). Late recovery of cardiac function after coronary artery reperfusion. Circulation, 51, Suppl II, 21, abstract.Google Scholar
  38. RUDE, R.E., MULLER, J.E. and BRAUNWALD, E. (1981). Efforts to limit the size of myocardial infarcts. Ann. intern. Med., 95, (6) 736–761.PubMedCrossRefGoogle Scholar
  39. SAXENA, P.R. (1983). Beta-adrenoceptor antagonists and blood flow to the jeopardized myocardium. Eur Heart J., 4, Suppl D, 101–108.Google Scholar
  40. SCHAPER, W. (1983). Natural defense mechanisms to ischemia. Eur. Heart J., 4, Suppl. D. 73–78.Google Scholar
  41. SERRUYS, P.W., BROWER, R.W., TEN KATEN, H.J. and MEESTER, G.T. (1980). Recovery from circulation depression after coronary artery bypass surgery. Eur. Surg. Res., 12, 369–382.PubMedCrossRefGoogle Scholar
  42. SERRUYS, P.W., VAN DEN BRAND, M., HOOGHOUDT, T.E.H., SIMOONS, M.L., FIORETTI, P., RUITER, J., FELS, F. and HUGENHOLTZ, P.G. (1982). Coronary recanalization in acute myocardial infarction: Immediate results and potential risks. Eur. Heart J., 3, 404–415.PubMedGoogle Scholar
  43. SERRUYS, P.W., VAN DEN BRAND, M., BROWER, R.W. and HUGENHOLTZ, P.G. (1984). Left ventricular Hemodynamics, Regional Blood Flow, and Lactate Metabolism During Balloon Occlusion: Can We Alter the Sequence of Ischemic Events? In Silent Myocardial Ischemia. Rutishauser, W. and Roskamm, H. (eds) pp. 37–44, Berlin: Springer Verlag.Google Scholar
  44. SHARMA, G.V.R.K., CELLA, G., PARISI, A.F. and SASAHARA, A.A. (1982). Thrombolytic Therapy. New Eng. J. Med., 306, 1268–1276.PubMedCrossRefGoogle Scholar
  45. SIMOONS, M.L., BALAKUMARAN, K., SERRUYS, P.W., VAN DEN BRAND, M., FIORETTI, P., REIBER, J.H.C., LIE, P. and HUGENHOLTZ, P.G. (1982). The effect of intracoronary thrombolysis with streptokinase on myocardial thallium redistribution and global and regional left ventricular function. Eur. Heart J., 2, 433–440.Google Scholar
  46. VAN DER GIESSEN, W.J., MOOI, W., RUTTEN, A.M., VAN VLIET, H.H.D.M., SLAGER, C.J. and VERDOUW, P.D. (1983). A new model for coronary thrombosis in the pig; preliminary results with thrombolysis. Eur. Heart J., 4, Suppl C, 69–77.Google Scholar
  47. VANHALEWEYK, G.L.J., SERRUYS, P.W. and HUGENHOLTZ, P.G. (1983). Antianginal electrophysiologic and hemodynamic effects of combined beta-blocker-calcium antagonist therapy. Eur. Heart J., 4, Suppl D, 117–128.Google Scholar
  48. VERDOUW, P.D., HARTOG, J.M. and TEN CATE, F.J. (1981). Effects of nifedipine on the recovery of regional myocardial performance during reperfusion of ischemic myocardium. Prog. Pharmac., 4, (2) 91–100.Google Scholar
  49. VERDOUW, P.D., WOLFFENBUTTEL, B.H.R. and TEN CATE, F.J. (1983). Nifedipine with and without propranolol in the treatment of myocardial ischemia. Effect on ventricular arrhythmias and recovery of regional wall function. Eur. Heart J., 4, Suppl B, (in press).Google Scholar
  50. VÖHRINGER, H.F., LINDERER, T.H. and SCHRÖDER, R. (1984). Intravenöse Streptokinase Behandlung beim Acuten Myokardinfarkt: Langzeitverlauf. Zeitschr. für Kardiol., 73, 45.Google Scholar
  51. ANAND, I.S., PHARMA, P.L., CHAKRAVARTI, R.N. and WAHI, P.L. (1980). Experimental myocardial infarction in rhesus monkeys. Verapamil pretreatment in the reduction of infarct size. Adv. Myocardiol., 2, 425–433.PubMedGoogle Scholar
  52. CAIRNS, J.A. and KLASSEN, G.A. (1981). Intravenous propranolol therapy for acute myocardial infarction in man: hemodynamic and serial creatine kinase assessment. Chest, 79, (3) 227–285.CrossRefGoogle Scholar
  53. FIEDLER, V.B. (1981). Effects of molsidomine on coronary artery thrombosis and myocardial ischemia in acute canine experiments. Eur. J. Pharmac., 73, (1), 85–9.CrossRefGoogle Scholar
  54. JOHANNSSON, B.W. (1980). A comparative study of cardioselective beta-blockade and diazepam in patients with acute myocardial infarction and tachycardia. Acta med. scand., 207, (1–2), 47–53.Google Scholar
  55. LIE, K.I. and FIOLET, J.W. (1983). Beta-blockade and acute myocardial infarction. Eur. Heart J., 4, Suppl D 167–171.Google Scholar
  56. MELIN, J.A. and BECKER, L.C. (1983). Salvage of ischemic myocardium by prostacyclin during experimental myocardial infarction. J. Am. Coll. Cardiol., 2, (2) 279–286.PubMedCrossRefGoogle Scholar
  57. MULLER, J.E. and BRAUNWALD, E. (1983). Can Infarct size be limited in patients with acute myocardial infarction? Cardiovasc. Clin. 13, (1) 147–161.PubMedGoogle Scholar
  58. OLSSON, G., REHNQVIST, N., LUNDMAN, T. and MELCHER, A. (1981). Metoprolol treatment after acute myocardial infarction. Effects on ventricular arrhythmias and exercise tests during 6 months. Acta med. scand., 210, (1–2), 59–65.PubMedGoogle Scholar
  59. ROBERTS, R. (1983). Intravenous nitroglycerin in acute myocardial infarction. Am. J. Med., 74, (6b) 45–52.PubMedCrossRefGoogle Scholar
  60. ROGERS, G.G., ROSENDORFF, C., SHIMELL, C.J. and COULL, A. (1982). Effects of tiapamil on haemodynamics and myocardial salvage during myocardial infarction in the baboon. Cardiology, 69, (Suppl.) 58–67.PubMedCrossRefGoogle Scholar
  61. RUDE, R.E., MULLER, J.E. and BRAUNWALD, E. (1981). Efforts to limit the size of myocardial infarcts. Ann. intern. Med., 95, (6), 736–761.PubMedCrossRefGoogle Scholar
  62. SHEEHAN, F.H., MATHEY, D.G., SCHOFER, J., KREBBER, H.J. and DODGE, H.T. (1983). Effect of interventions in salvaging left ventricular function in acute myocardial infarction: a study of intracoronary streptokinase. Am. J. Cardiol., 52, (5) 431–438.PubMedCrossRefGoogle Scholar
  63. STACK, R.S., PHILLIPS, H.R. (3d), GRIERSON, D.S., BEHAR, V.S., KONG, Y., PETER, R.H., SWAIN, J.L. and GREENFIELD, J.C.Jr (1982). Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction. J. clin. Invest., 72, (1) 84–95.CrossRefGoogle Scholar
  64. TONKIN, A.M., JOEL, S.E., REYNOLDS, J.L., AYLWARD, P.E., HEDDLE, W.F., McRITCHIE, R.J., WEST, M.J. and CHALMERS, J.P. (1981). Beta-blockade in acute myocardial infarction. Inability of relatively late administration to influence infarct size and arrhythmias. Med. J. Aust., 2, (3) 145–146.PubMedGoogle Scholar
  65. YUSUF, S., RAMSDALE, D., PETO, R., FURSE, L., BENNETT, D., BRAY, C. and SLEIGHT, P. (1980). Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomized trial. Lancet, ii, (8189) 273–276.Google Scholar

Copyright information

© Macmillan Publishers Limited 1984

Authors and Affiliations

  • P. G. Hugenholtz
    • 1
  • J. W. Deckers
    • 1
  • W. J. van der Giessen
    • 1
  • P. S. Serruys
    • 1
  • J. Lubsen
    • 1
  1. 1.Thoraxcenter, Division of CardiologyUniversity HospitalRotterdamThe Netherlands

Personalised recommendations